arikayce
(Amikacin)Insmed Incorporated
Usage: ARIKAYCE® is indicated for adults with refractory Mycobacterium avium complex (MAC) lung disease who lack alternative treatment options. It is used as part of a combination antibacterial regimen when patients do not achieve negative sputum cultures after at least 6 months of prior therapy.